亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis

医学 放化疗 荟萃分析 病态的 基底细胞 肿瘤科 新辅助治疗 内科学 完全响应 胃肠病学 化疗 癌症 乳腺癌
作者
Xing Gao,Hidde C.G. Overtoom,Ben M. Eyck,Shi-Han Huang,Daan Nieboer,Pieter C. van der Sluis,Sjoerd M. Lagarde,Bas P. L. Wijnhoven,Yin‐Kai Chao,J. Jan B. van Lanschot
出处
期刊:British Journal of Surgery 卷期号:111 (5)
标识
DOI:10.1093/bjs/znae083
摘要

Abstract Objective Locally advanced oesophageal squamous cell carcinoma can be treated with neoadjuvant chemoradiotherapy or chemotherapy followed by oesophagectomy. Discrepancies in pathological response rates have been reported between studies from Eastern versus Western countries. The aim of this study was to compare the pathological response to neoadjuvant chemoradiotherapy in Eastern versus Western countries. Methods Databases were searched until November 2022 for studies reporting pCR rates after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma. Multi-level meta-analyses were performed to pool pCR rates separately for cohorts from studies performed in centres in the Sinosphere (East) or in Europe and the Anglosphere (West). Results For neoadjuvant chemoradiotherapy, 51 Eastern cohorts (5636 patients) and 20 Western cohorts (3039 patients) were included. Studies from Eastern countries included more men, younger patients, more proximal tumours, and more cT4 and cN+ disease. Patients in the West were more often treated with high-dose radiotherapy, whereas patients in the East were more often treated with a platinum + fluoropyrimidine regimen. The pooled pCR rate after neoadjuvant chemoradiotherapy was 31.7% (95% c.i. 29.5% to 34.1%) in Eastern cohorts versus 40.4% (95% c.i. 35.0% to 45.9%) in Western cohorts (fixed-effect P = 0.003). For cohorts with similar cTNM stages, pooled pCR rates for the East and the West were 32.5% and 41.9% respectively (fixed-effect P = 0.003). Conclusion The pathological response to neoadjuvant chemoradiotherapy is less favourable in patients treated in Eastern countries compared with Western countries. Despite efforts to investigate accounting factors, the discrepancy in pCR rate cannot be entirely explained by differences in patient, tumour, or treatment characteristics.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
虞不斜完成签到 ,获得积分10
12秒前
冬去春来完成签到 ,获得积分10
24秒前
40秒前
lovelife完成签到,获得积分10
1分钟前
充电宝应助112采纳,获得10
2分钟前
Akim应助反对法v的采纳,获得10
3分钟前
虚心的麦片发布了新的文献求助200
3分钟前
3分钟前
月军完成签到,获得积分10
3分钟前
112发布了新的文献求助10
3分钟前
3分钟前
反对法v的发布了新的文献求助10
3分钟前
我是老大应助taozixiaoxiao采纳,获得10
3分钟前
4分钟前
taozixiaoxiao发布了新的文献求助10
4分钟前
慕青应助拼搏的不评采纳,获得10
6分钟前
7分钟前
害羞雨莲发布了新的文献求助10
7分钟前
虚心的麦片完成签到,获得积分10
7分钟前
小马甲应助害羞雨莲采纳,获得10
7分钟前
7分钟前
7分钟前
chiazy完成签到 ,获得积分10
7分钟前
7分钟前
草木完成签到,获得积分10
7分钟前
8分钟前
Jasper应助正直的山雁采纳,获得10
8分钟前
段誉完成签到 ,获得积分10
9分钟前
10分钟前
10分钟前
景灵松完成签到,获得积分10
10分钟前
星辰大海应助正直的山雁采纳,获得10
11分钟前
萝卜丁完成签到 ,获得积分10
12分钟前
虚心的麦片关注了科研通微信公众号
12分钟前
13分钟前
汉堡包应助扶正与祛邪采纳,获得10
13分钟前
13分钟前
陈无敌完成签到 ,获得积分10
13分钟前
13分钟前
上官若男应助taozixiaoxiao采纳,获得10
14分钟前
高分求助中
The ACS Guide to Scholarly Communication 2500
Sustainability in Tides Chemistry 2000
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
Genera Insectorum: Mantodea, Fam. Mantidæ, Subfam. Hymenopodinæ (Classic Reprint) 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3085446
求助须知:如何正确求助?哪些是违规求助? 2738299
关于积分的说明 7548877
捐赠科研通 2387920
什么是DOI,文献DOI怎么找? 1266230
科研通“疑难数据库(出版商)”最低求助积分说明 613352
版权声明 598584